• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

A radioimmunoassay to measure piretanide in human serum and urine.

作者信息

Heptner W, Baudner S, Dagrosa E E, Hellstern C, Irmisch R, Strecker H, Wissmann H

出版信息

J Immunoassay. 1984;5(1-2):13-27. doi: 10.1080/01971528408062996.

DOI:10.1080/01971528408062996
PMID:6715550
Abstract

This paper describes a specific radioimmunological method for determining the diuretic agent piretanide (4 phenoxy-3-(1-pyrrolidinyl)-5-sulfamoyl benzoic acid) in human serum, plasma and urine. The antiserum was raised in rabbits against an immunogen of piretanide coupled to bovine serum albumin. The iodinated hydroxy derivative of piretanide was used as tracer. The separation of free and antibody-bound piretanide was performed by precipitating the antibody-tracer complex by polyethylene glycol. The limit of detection was 4 ng/ml. Studies on specificity showed less than 0.5% cross-reactivity of an identified metabolite. Interassay reproducibility showed an average coefficient of variation of 7.3%, the interassay variation was 5%. A recovery experiment yielded 100.9% recovery. There is good agreement between parallel determinations of piretanide by RIA and HPLC in both human serum and urine.

摘要

相似文献

1
A radioimmunoassay to measure piretanide in human serum and urine.
J Immunoassay. 1984;5(1-2):13-27. doi: 10.1080/01971528408062996.
2
Determination of tiamenidine in biological specimens by radioimmunoassay.用放射免疫分析法测定生物样品中的噻美尼定。
Arzneimittelforschung. 1981;31(3):419-24.
3
Radioimmunoassay of detirelix ([ N-Ac-D-Nal(2)1,D-p-Cl-Phe2,D-Trp3, D-hArg(Et)6(2),D-Ala10]-luteinizing hormone-releasing hormone) in plasma or serum.
J Immunoassay. 1988;9(3-4):245-55. doi: 10.1080/01971528808053215.
4
Vascular effects of piretanide. Studies on extrarenal action in several animal models.吡咯他尼的血管作用。在几种动物模型中的肾外作用研究。
Arzneimittelforschung. 1983;33(9):1273-6.
5
Stability-indicating methods for the determination of piretanide in presence of the alkaline induced degradates.在碱性诱导降解产物存在的情况下测定吡咯他尼的稳定性指示方法。
J Pharm Biomed Anal. 2005 Oct 4;39(5):871-6. doi: 10.1016/j.jpba.2005.02.035. Epub 2005 Apr 22.
6
Determination of piretanide and furosemide in pharmaceuticals and human urine by high-performance liquid chromatography with amperometric detection.
J Chromatogr B Biomed Appl. 1996 Jan 26;675(2):303-12. doi: 10.1016/0378-4347(95)00349-5.
7
Renal effects of piretanide in dogs.吡咯他尼对犬类的肾脏影响。
Arzneimittelforschung. 1983;33(9):1277-80.
8
Piretanide: a new synthetic fibrinolytic and anti-platelet agent.吡咯他尼:一种新型合成纤维蛋白溶解剂和抗血小板剂。
Thromb Haemost. 1986 Dec 15;56(3):360-3.
9
Urinary and plasma urodilatin measured by a direct RIA using a highly specific antiserum.使用高特异性抗血清通过直接放射免疫分析法测定尿液和血浆中的尿舒张素。
Clin Chem. 1998 Dec;44(12):2524-9.
10
Detection of aflatoxins and related metabolites by radioimmunoassay.
J Natl Cancer Inst. 1982 Dec;69(6):1375-81.

引用本文的文献

1
Pharmacokinetics and pharmacodynamics of ramipril and piretanide administered alone and in combination.单独及联合使用雷米普利和吡咯他尼的药代动力学和药效学。
Eur J Clin Pharmacol. 1994;46(6):545-50. doi: 10.1007/BF00196113.
2
Pharmacodynamics and urine pharmacokinetics of three doses of piretanide.三种剂量的吡咯他尼的药效学和尿药代动力学
Eur J Clin Pharmacol. 1983;25(6):783-5. doi: 10.1007/BF00542520.
3
Pharmacokinetics of high doses of piretanide in moderate to severe renal failure.高剂量吡咯他尼在中重度肾衰竭患者中的药代动力学
Eur J Clin Pharmacol. 1984;27(5):589-93. doi: 10.1007/BF00556897.
4
Pharmacokinetics of the loop diuretic piretanide in renal failure.
Eur J Clin Pharmacol. 1985;29(3):337-43. doi: 10.1007/BF00544091.
5
Piretanide. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.吡咯他尼。对其药效学、药代动力学特性及治疗效果的初步综述。
Drugs. 1985 Jun;29(6):489-530. doi: 10.2165/00003495-198529060-00002.
6
The absorption of piretanide from the gastro-intestinal tract is site-dependent.
Eur J Clin Pharmacol. 1986;30(1):79-82. doi: 10.1007/BF00614200.
7
Clinical pharmacokinetics of some newer diuretics.一些新型利尿剂的临床药代动力学
Clin Pharmacokinet. 1987 Oct;13(4):254-66. doi: 10.2165/00003088-198713040-00003.